Skip to main content
OpenTrials

Clinical trial condition

Overactive Bladder

Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.

362 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Overactive Bladder trial results

Completed

Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder

NCT00224146

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations
  • Mobile, Alabama, United States
  • Tucson, Arizona, United States
  • Torrance, California, United States
  • Rocky Hill, Connecticut, United States
View Trial Details
Completed

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

NCT00857896

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Long Beach, California, United States
  • Pfizer Investigational Site Overland Park, Kansas, United States
  • Pfizer Investigational Site Overland Park, Kansas, United States
View Trial Details
Completed

Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)

NCT00862745

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 13 locations
View Trial Details
Completed

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Pfizer Investigational Site Kowloon, Hong Kong
  • Pfizer Investigational Site Shatin, Hong Kong
  • Pfizer Investigational Site Nagoya, Aichi-ken, Japan
  • Pfizer Investigational Site Chuo-ku, Chiba-shi, Chiba, Japan
View all 65 locations
View Trial Details
Completed

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

NCT00611026

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Pfizer Investigational Site Enterprise, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Montgomery, Alabama, United States
  • Pfizer Investigational Site Chandler, Arizona, United States
View all 227 locations
View Trial Details

Related conditions